David Veitch
Director Ejecutivo en BASILEA PHARMACEUTICA AG .
Fortuna: 55 989 $ al 30/04/2024
Cargos activos de David Veitch
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BASILEA PHARMACEUTICA AG | Director Ejecutivo | 19/04/2018 | - |
| Corporate Officer/Principal | 01/09/2014 | 19/04/2018 |
Historial de carrera de David Veitch
Antiguos cargos conocidos de David Veitch.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2012 | 01/01/2013 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Corporate Officer/Principal | 01/01/2004 | 01/01/2011 |
Formación de David Veitch.
| University of Bristol | Undergraduate Degree |
Estadísticas
Internacional
| Reino Unido | 3 |
| Suiza | 2 |
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Chief Executive Officer | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BASILEA PHARMACEUTICA AG | Health Technology |
| Empresas privadas | 2 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Health Technology |
- Bolsa de valores
- Insiders
- David Veitch
- Experiencia
